DuPont de Nemours Valuation

Is 0A6B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0A6B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0A6B ($83.39) is trading below our estimate of fair value ($149.76)

Significantly Below Fair Value: 0A6B is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0A6B?

Key metric: As 0A6B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0A6B. This is calculated by dividing 0A6B's market cap by their current earnings.
What is 0A6B's PE Ratio?
PE Ratio68.6x
EarningsUS$508.00m
Market CapUS$34.82b

Price to Earnings Ratio vs Peers

How does 0A6B's PE Ratio compare to its peers?

The above table shows the PE ratio for 0A6B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.4x
CRDA Croda International
30.4x15.1%UK£4.9b
JMAT Johnson Matthey
23.8x28.4%UK£2.6b
VCT Victrex
24.9x37.8%UK£763.5m
TET Treatt
22.6x15.3%UK£255.9m
0A6B DuPont de Nemours
68.6x23.7%US$34.8b

Price-To-Earnings vs Peers: 0A6B is expensive based on its Price-To-Earnings Ratio (68.6x) compared to the peer average (25.4x).


Price to Earnings Ratio vs Industry

How does 0A6B's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0A6B 68.6xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0A6B is expensive based on its Price-To-Earnings Ratio (68.6x) compared to the European Chemicals industry average (17.1x).


Price to Earnings Ratio vs Fair Ratio

What is 0A6B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0A6B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio68.6x
Fair PE Ratio25.7x

Price-To-Earnings vs Fair Ratio: 0A6B is expensive based on its Price-To-Earnings Ratio (68.6x) compared to the estimated Fair Price-To-Earnings Ratio (25.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0A6B forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$83.97
US$96.00
+14.3%
13.2%US$107.00US$52.00n/a16
Nov ’25US$82.49
US$94.60
+14.7%
13.2%US$105.00US$52.00n/a17
Oct ’25US$88.26
US$93.42
+5.8%
13.2%US$105.00US$52.00n/a17
Sep ’25US$83.65
US$93.13
+11.3%
13.1%US$105.00US$52.00n/a17
Aug ’25US$81.91
US$92.07
+12.4%
13.0%US$105.00US$52.00n/a17
Jul ’25US$79.14
US$89.78
+13.4%
13.1%US$103.00US$52.00n/a17
Jun ’25US$81.06
US$89.78
+10.8%
13.1%US$103.00US$52.00n/a17
May ’25US$77.42
US$79.75
+3.0%
11.9%US$90.00US$52.00n/a16
Apr ’25US$76.86
US$75.94
-1.2%
13.3%US$100.00US$52.00n/a16
Mar ’25US$69.79
US$75.38
+8.0%
13.0%US$100.00US$52.00n/a16
Feb ’25US$61.92
US$76.00
+22.7%
13.4%US$100.00US$52.00n/a16
Jan ’25US$76.75
US$80.06
+4.3%
12.4%US$92.00US$49.00n/a16
Dec ’24US$72.49
US$78.69
+8.5%
12.8%US$92.00US$49.00n/a16
Nov ’24US$66.74
US$79.08
+18.5%
14.8%US$92.00US$49.00US$82.4917
Oct ’24US$74.72
US$81.55
+9.1%
12.6%US$92.00US$49.00US$88.2617
Sep ’24US$77.90
US$81.79
+5.0%
12.3%US$92.00US$49.00US$83.6518
Aug ’24US$77.34
US$78.18
+1.1%
11.9%US$92.00US$49.00US$81.9118
Jul ’24US$71.71
US$76.91
+7.3%
12.4%US$92.00US$52.00US$79.1419
Jun ’24US$67.34
US$77.24
+14.7%
12.6%US$92.00US$52.00US$81.0618
May ’24US$67.74
US$83.47
+23.2%
12.6%US$103.00US$52.00US$77.4217
Apr ’24US$71.55
US$84.24
+17.7%
12.8%US$103.00US$52.00US$76.8617
Mar ’24US$74.16
US$84.11
+13.4%
14.0%US$103.00US$45.00US$69.7918
Feb ’24US$73.13
US$80.32
+9.8%
14.8%US$103.00US$45.00US$61.9219
Jan ’24US$69.05
US$79.53
+15.2%
14.8%US$103.00US$45.00US$76.7519
Dec ’23US$70.41
US$77.83
+10.5%
13.9%US$95.00US$45.00US$72.4918
Nov ’23US$59.06
US$69.96
+18.5%
17.4%US$95.00US$45.00US$66.7418

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies